LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death ...
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 1 oktober 2025